Intelerad Medical Systems Acquires Lumedx

Enterprise medical imaging systems provider Intelerad Medical Systems acquired cardiovascular intelligence software company Lumedx for an undisclosed amount.

Last year, Hg, a European investor in software and services focused on backing business, acquired Intelerad from Novacap’s TMT IV Fund for an undisclosed amount.

This is the third acquisition by Intelerad in the past six months. Intelerad recently acquired Digisonics, a picture archiving and communication system (PACS) for healthcare providers.

Intelerad says the latest acquisition expands its offerings through an expanded suite of solutions, further establishing the company in the cardiovascular space.

“Healthcare as we know it has forever changed, and more than ever, providers need automated solutions that allow them to focus on what they do best – treating patients and providing improved patient care,” said Mike Lipps, CEO of Intelerad. “Bringing LUMEDX into the Intelerad portfolio further enables our team to provide customers with the most comprehensive enterprise imaging platform in the industry.”

Lumedx helps improve care continuity through its cardiovascular data intelligence and cardiovascular information systems (CVIS), according to the company. It also provides analytics for multiple specialties, including orthopedics, neurology, spine, and maternal/fetal medicine. The company currently serves over 150 hospitals and health systems.

“Over the last two and a half decades, LUMEDX has been laser-focused on our vision of delivering an end-to-end suite of software and services that improves continuity of care,” said Allyn McAuley, Ph.D., CEO, and Co-Founder of LUMEDX. “Joining forces with Intelerad enables us to achieve this goal further, as well as provide customers increased automation that results in greater clinical efficiency and improved patient care.”

A total of 184 digital health companies were acquired in 2020, compared to 169 in 2019, according to Mercom’s Q4 and 2020 Digital Health Funding and M&A Report.